Your browser doesn't support javascript.
loading
Vaccine microarray patch self-administration: An innovative approach to improve pandemic and routine vaccination rates.
Hacker, E; Baker, B; Lake, T; Ross, C; Cox, M; Davies, C; Skinner, S R; Booy, R; Forster, A.
Afiliación
  • Hacker E; Vaxxas Pty Ltd, Translational Research Institute, Woolloongabba, Australia; Menzies Health Institute Queensland, Griffith University, Brisbane, QLD 4222, Australia.
  • Baker B; Vaxxas Pty Ltd, Translational Research Institute, Woolloongabba, Australia.
  • Lake T; Vaxxas Pty Ltd, Translational Research Institute, Woolloongabba, Australia.
  • Ross C; Vaxxas Pty Ltd, Translational Research Institute, Woolloongabba, Australia.
  • Cox M; NextWaveBio, East Haven, CT, United States.
  • Davies C; Specialty of Child and Adolescent Health, The Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Westmead, Australia; Sydney Institute of Infectious Diseases, University of Sydney, Sydney, Australia.
  • Skinner SR; Specialty of Child and Adolescent Health, The Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Westmead, Australia; Sydney Institute of Infectious Diseases, University of Sydney, Sydney, Australia.
  • Booy R; Specialty of Child and Adolescent Health, The Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Westmead, Australia; Sydney Institute of Infectious Diseases, University of Sydney, Sydney, Australia.
  • Forster A; Vaxxas Pty Ltd, Translational Research Institute, Woolloongabba, Australia. Electronic address: aforster@vaxxas.com.
Vaccine ; 41(41): 5925-5930, 2023 09 22.
Article en En | MEDLINE | ID: mdl-37643926
ABSTRACT
The high-density microprojection array patch (HD-MAP) is a novel vaccine delivery system with potential for self-administered vaccination. HD-MAPs provide an alternative to needle and syringe (N&S) vaccination. Additional advantages could include reduced cold-chain requirements, reduced vaccine dose, reduced vaccine wastage, an alternative for needle phobic patients and elimination of needlestick injuries. The drivers and potential benefits of vaccination by self-administering HD-MAPs are high patient acceptance and preference, higher vaccination rates, speed of roll-out, cost-savings, and reduced sharps and environmental waste. The HD-MAP presents a unique approach in pandemic preparedness and routine vaccination of adults. It could alleviate strain on the healthcare workforce and allows vaccine administration by minimally-trained workers, guardian or subjects themselves. Self-vaccination using HD-MAPs could occur in vaccination hubs with supervision, at home after purchasing at the pharmacy, or direct distribution to in-home settings. As a result, it has the potential to increase vaccine coverage and expand the reach of vaccines, while also reducing labor costs associated with vaccination. Key challenges remain around shifting the paradigm from medical professionals administrating vaccines using N&S to a future of self-administration using HD-MAPs. Greater awareness of HD-MAP technology and improving our understanding of the implementation processes required for adopting this technology, are critical factors underpinning HD-MAP uptake by the public.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_enfermedades_transmissibles Asunto principal: Vacunas / Pandemias Límite: Adult / Humans Idioma: En Revista: Vaccine Año: 2023 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_enfermedades_transmissibles Asunto principal: Vacunas / Pandemias Límite: Adult / Humans Idioma: En Revista: Vaccine Año: 2023 Tipo del documento: Article País de afiliación: Australia
...